NCT04114994 Longitudinal Cognitive Assessment by BoCA
| NCT ID | NCT04114994 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Alzheimer's Light LLC |
| Condition | Alzheimer Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2019-10-01 |
| Primary Completion | 2029-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2019-10-01 with a primary completion date of 2029-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Boston Cognitive Assessment (BoCA) is a self-administered online test intended for longitudinal cognitive monitoring. BoCA uses random not-repeating tasks to minimize learning effects. BoCA was developed to evaluate the effects of treatment in longitudinal clinical trials and available gratis to individuals and professionals.
Eligibility Criteria
Inclusion Criteria: age 50 or older Exclusion Criteria: younger than 50 years
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04114994 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Alzheimer Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04114994 currently recruiting?
Yes, NCT04114994 is actively recruiting participants. Contact the research team at vysha@bu.edu for enrollment information.
Where is the NCT04114994 trial being conducted?
This trial is being conducted at Miami, United States.
Who is sponsoring the NCT04114994 clinical trial?
NCT04114994 is sponsored by Alzheimer's Light LLC. The trial plans to enroll 10,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.